Innoviva
Price & Volume
Stats
See moreOpen | $19.56 |
Previous Close | $19.55 |
Day Range | $19.39-$19.58 |
52W Range | $16.52-$22.76 |
Market Cap | $1.6B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $388.5M |
Revenue Growth (YoY) | 20.4% |
Gross Profit (12 Mos) | $328.3M |
Diluted EPS | $1.66 |
News
See moreYahoo Finance • last month
H.C. Wainwright Lifts PT on Innoviva (INVA) to $46 From $45, Keeps a Buy Rating
Yahoo Finance • last month
FDA Approves Innoviva's NUZOLVENCE, First-in-Class Oral Treatment For Gonorrhea
Yahoo Finance • 3 months ago
Innoviva, Inc. Reports Increase In Q3 Income
Yahoo Finance • 3 months ago
Top FDA official Tidmarsh resigns after comments on kidney drug, HHS probe
About
CEO | Mr. Pavel Raifeld C.F.A. |
Address | 1350 Old Bayshore Highway, Burlingame, CA, United States, 94010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 127 |
